DCTER Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** An induction regimen consisting of dexamethasone, cytarabine, thioguanine, etoposide and daunorubucin (or rubidomycin), administered on an intensively-timed schedule as a form of timed-sequential therapy and used for the treatment of childhood acute myeloid leukemia.

**Synonyms:** - COG 2891 Study Regimen - Cytarabine/Daunorubicin/Dexamethasone/Etoposide/Thioguanine Regimen - DCTER